RxDoctor Payments Data

Amy Causey

Physician Assistant · Baxley, GANPI 1356576268

Payments from drug & device makers

$475in general payments, 2019–2025

Across 28 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$137
  • Antares Pharma, Inc.$66
  • Lilly USA, LLC$65
  • Novartis$51
  • Boehringer Ingelheim$29
  • Inspire Medical Systems, Inc.$23
  • plus $106 from 6 others

What the payments were for

  • Food & beverage$46398%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$475 in reported general payments places this provider in the 55th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$28,271
Medicare patients
119
Services billed
684

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide124$142,043
MounjaroTirzepatide95$102,784
EliquisApixaban43$37,566
LinzessLinaclotide31$18,360
XareltoRivaroxaban19$17,347
JanuviaSitagliptin Phosphate21$17,059
EntrestoSacubitril/Valsartan24$15,822
JardianceEmpagliflozin15$13,898
FarxigaDapagliflozin Propanediol18$9,807
BrilintaTicagrelor17$8,437
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$7,361
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$4,387
Dexlansoprazole DrDexlansoprazole13$3,136
SymbicortBudesonide/Formoterol Fumarate13$3,035
LantusInsulin Glargine,hum.Rec.Anlog21$2,502

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$137$142,043124 claims
Lilly USA, LLCMounjaro$65$102,78495 claims
PfizerEliquis$21$37,56643 claims
AstraZenecaFarxiga, Brilinta, Symbicort$16$21,28048 claims
NovartisEntresto$51$15,82224 claims
Boehringer IngelheimJardiance$29$13,89815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Baxley

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →